The White House has finally addressed the cannabis industry, but its comments have left many stakeholders feeling uncertain. During the presidential campaign, part of the cannabis industry supported the new president, believing he would act quickly to implement reforms. However, the administration’s current stance reveals a lack of clear direction, which is concerning for businesses and advocates alike.
The cannabis industry has provided benefits for consumers, medical patients, and veterans in legal states. Nevertheless, for many small businesses, the reality has been challenging. Despite high demand, federal restrictions on taxes and banking have created significant hurdles for growth and expansion. Although some industry members were hopeful that the new administration would foster positive changes, they now face opposition from key figures, including House Speaker Mike Johnson.
A White House official recently confirmed that “no action is being considered at this time” regarding marijuana policy. This statement highlights the administration’s inaction despite earlier campaign promises to support cannabis reforms. The president had expressed intentions to reschedule marijuana under the Controlled Substances Act (CSA), moving it from Schedule I to Schedule III. This change would ease restrictions on medical use and allow cannabis businesses to access banking and tax benefits. However, since taking office, no substantial steps have been taken to advance this initiative.
In addition to rescheduling, the president has shown support for state autonomy regarding cannabis policy and has endorsed state-level legalization efforts, such as Florida’s unsuccessful 2024 ballot measure for recreational marijuana. While these positions reflect a more favorable approach compared to his earlier term, the administration has not prioritized important federal reforms, including the SAFE Banking Act, which would provide banking services to cannabis businesses. Efforts to include such measures in a government funding bill last year were not successful.
The lack of federal action has significant consequences for the cannabis industry. Rescheduling marijuana could reduce financial burdens by removing restrictions under IRS Code Section 280E and encouraging medical research. However, the current stalled process leaves businesses grappling with regulatory uncertainties and limited access to financial resources. As stakeholders continue to lobby for reform, the administration appears to focus on other issues, such as immigration and foreign policy.
English 
Spanish 
German 
Czech